标题
Smart cancer nanomedicine
作者
关键词
-
出版物
Nature Nanotechnology
Volume 14, Issue 11, Pages 1007-1017
出版商
Springer Science and Business Media LLC
发表日期
2019-11-07
DOI
10.1038/s41565-019-0567-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
- (2019) Daniel Shae et al. Nature Nanotechnology
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- Blood-Brain Barrier Opening in Primary Brain Tumors with Non-invasive MR-Guided Focused Ultrasound: A Clinical Safety and Feasibility Study
- (2019) Todd Mainprize et al. Scientific Reports
- Interferons α and β in cancer: therapeutic opportunities from new insights
- (2019) Ernest C. Borden NATURE REVIEWS DRUG DISCOVERY
- Sodium bicarbonate nanoparticles modulate the tumor pH and enhance the cellular uptake of doxorubicin
- (2019) Hanan Abumanhal-Masarweh et al. JOURNAL OF CONTROLLED RELEASE
- A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients
- (2019) Yasuhiro Fujiwara et al. BRITISH JOURNAL OF CANCER
- Therapeutic targeting of trained immunity
- (2019) Willem J. M. Mulder et al. NATURE REVIEWS DRUG DISCOVERY
- A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2Rβγ-Biased Cytokine, in Patients with Advanced or Metastatic Solid Tumors
- (2019) Salah-Eddine Bentebibel et al. Cancer Discovery
- Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer
- (2019) Janet E. Murphy et al. JAMA Oncology
- Impact of 68 Ga-PSMA PET on the Management of Patients with Prostate Cancer: A Systematic Review and Meta-analysis
- (2018) Sangwon Han et al. EUROPEAN UROLOGY
- CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia
- (2018) Jeffrey E. Lancet et al. JOURNAL OF CLINICAL ONCOLOGY
- Histidine-rich glycoprotein-induced vascular normalization improves EPR-mediated drug targeting to and into tumors
- (2018) Benjamin Theek et al. JOURNAL OF CONTROLLED RELEASE
- Multi-modal characterization of vasculature and nanoparticle accumulation in five tumor xenograft models
- (2018) Einar Sulheim et al. JOURNAL OF CONTROLLED RELEASE
- Asparagine bioavailability governs metastasis in a model of breast cancer
- (2018) Simon R. V. Knott et al. NATURE
- Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours
- (2018) Javier Garcia-Bermudez et al. NATURE CELL BIOLOGY
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Safety of combining radiotherapy with immune-checkpoint inhibition
- (2018) William L. Hwang et al. Nature Reviews Clinical Oncology
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Personalized vaccines for cancer immunotherapy
- (2018) Ugur Sahin et al. SCIENCE
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis
- (2018) Sara Bravaccini et al. Scientific Reports
- Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer
- (2018) Karen A. Autio et al. JAMA Oncology
- Potentially curative combination of TGF-b1 inhibitor losartan and FOLFIRINOX (FFX) for locally advanced pancreatic cancer (LAPC): R0 resection rates and preliminary survival data from a prospective phase II study.
- (2018) Janet E. Murphy et al. JOURNAL OF CLINICAL ONCOLOGY
- Minimum information reporting in bio–nano experimental literature
- (2018) Matthew Faria et al. Nature Nanotechnology
- Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway
- (2018) Jianqin Lu et al. ACS Nano
- Modular Nanoparticulate Prodrug Design Enables Efficient Treatment of Solid Tumors Using Bioorthogonal Activation
- (2018) Miles A. Miller et al. ACS Nano
- Sonopermeation to improve drug delivery to tumors: from fundamental understanding to clinical translation
- (2018) Sofie Snipstad et al. Expert Opinion on Drug Delivery
- Nanoparticles That Deliver RNA to Bone Marrow Identified by in Vivo Directed Evolution
- (2018) Cory D. Sago et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Roadmap and strategy for overcoming infusion reactions to nanomedicines
- (2018) Janos Szebeni et al. Nature Nanotechnology
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- New drug candidates for liposomal delivery identified by computer modeling of liposomes' remote loading and leakage
- (2017) Ahuva Cern et al. JOURNAL OF CONTROLLED RELEASE
- Balancing Passive and Active Targeting to Different Tumor Compartments Using Riboflavin-Functionalized Polymeric Nanocarriers
- (2017) Yoanna Tsvetkova et al. NANO LETTERS
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
- (2017) Yuanzeng Min et al. Nature Nanotechnology
- Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics
- (2017) James E. Dahlman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts
- (2017) Miles A. Miller et al. Science Translational Medicine
- Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
- (2017) Norbert Pardi et al. Nature Communications
- Rethinking cancer nanotheranostics
- (2017) Hongmin Chen et al. Nature Reviews Materials
- Designing nanomedicine for immuno-oncology
- (2017) Wen Jiang et al. Nature Biomedical Engineering
- Exploiting the Metal-Chelating Properties of the Drug Cargo for In Vivo Positron Emission Tomography Imaging of Liposomal Nanomedicines
- (2016) Scott Edmonds et al. ACS Nano
- P-214Salvage Chemoradiotherapy for Locally Recurrent Bile Duct Cancer
- (2016) J.I. Yu et al. ANNALS OF ONCOLOGY
- NKTR-214, an Engineered Cytokine with Biased IL2 Receptor Binding, Increased Tumor Exposure, and Marked Efficacy in Mouse Tumor Models
- (2016) D. H. Charych et al. CLINICAL CANCER RESEARCH
- Cancer nanomedicines: oversold or underappreciated?
- (2016) Roy van der Meel et al. Expert Opinion on Drug Delivery
- Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
- (2016) Christina Pfirschke et al. IMMUNITY
- Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin
- (2016) Grant H. Petersen et al. JOURNAL OF CONTROLLED RELEASE
- A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer
- (2016) Georg Dimcevski et al. JOURNAL OF CONTROLLED RELEASE
- Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
- (2016) Andrea Wang-Gillam et al. LANCET
- Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy
- (2016) Matthias A. Oberli et al. NANO LETTERS
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Regulation and function of the cGAS–STING pathway of cytosolic DNA sensing
- (2016) Qi Chen et al. NATURE IMMUNOLOGY
- Trained immunity: A program of innate immune memory in health and disease
- (2016) M. G. Netea et al. SCIENCE
- Clinical trial of blood-brain barrier disruption by pulsed ultrasound
- (2016) Alexandre Carpentier et al. Science Translational Medicine
- Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo
- (2016) Susan Ashton et al. Science Translational Medicine
- Augmenting drug–carrier compatibility improves tumour nanotherapy efficacy
- (2016) Yiming Zhao et al. Nature Communications
- Theranostic barcoded nanoparticles for personalized cancer medicine
- (2016) Zvi Yaari et al. Nature Communications
- Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy
- (2016) Carlos Pérez-Medina et al. Nature Communications
- Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors
- (2016) Claire F. Friedman et al. JAMA Oncology
- An MRI-based classification scheme to predict passive access of 5 to 50-nm large nanoparticles to tumors
- (2016) Anastassia Karageorgis et al. Scientific Reports
- Complete regression of breast tumour with a single dose of docetaxel-entrapped core-cross-linked polymeric micelles
- (2015) Qizhi Hu et al. BIOMATERIALS
- Mutant MHC class II epitopes drive therapeutic immune responses to cancer
- (2015) Sebastian Kreiter et al. NATURE
- Innate immune memory: a paradigm shift in understanding host defense
- (2015) Mihai G Netea et al. NATURE IMMUNOLOGY
- Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle
- (2015) Miles A. Miller et al. Science Translational Medicine
- Passive versus Active Tumor Targeting Using RGD- and NGR-Modified Polymeric Nanomedicines
- (2014) Sijumon Kunjachan et al. NANO LETTERS
- Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe
- (2014) E. Phillips et al. Science Translational Medicine
- Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
- (2013) Vikash P. Chauhan et al. Nature Communications
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Personalized Nanomedicine
- (2012) T. Lammers et al. CLINICAL CANCER RESEARCH
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
- (2012) J. Hrkach et al. Science Translational Medicine
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
- (2011) B. Diop-Frimpong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles
- (2009) C. H. J. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy
- (2008) T Lammers et al. BRITISH JOURNAL OF CANCER
- Cancer Cell Metabolism: Warburg and Beyond
- (2008) Peggy P. Hsu et al. CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started